US Broker Ratings

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Exploring a 78.47% Potential Upside for Savvy Investors

Eton Pharmaceuticals, Inc. (ETON), a burgeoning player in the healthcare sector, is garnering attention from investors with its impressive growth trajectory and promising financial outlook. Based in Deer Park, Illinois,..

Beta Bionics, Inc. (BBNX) Investor Outlook: A Healthcare Pioneer with Strong Revenue Growth and Analyst Confidence

Beta Bionics, Inc. (NASDAQ: BBNX) is making waves in the healthcare sector, specifically within the medical devices industry. Focused on improving the lives of individuals requiring insulin, this U.S.-based company..

Weave Communications, Inc. (WEAV) Stock Analysis: Exploring a 63.78% Potential Upside

Weave Communications, Inc. (NYSE: WEAV) is a burgeoning player in the Health Information Services industry, providing cutting-edge customer experience and payment software solutions to small and medium-sized healthcare businesses. With..

Upstream Bio, Inc. (UPB) Stock Analysis: A Biotech Gem with a 69% Upside Potential

Upstream Bio, Inc. (UPB), a promising player in the biotechnology sector, has captured investor interest with its focus on developing treatments for inflammatory diseases, particularly severe respiratory disorders. Headquartered in..

AxoGen, Inc. (AXGN) Stock Analysis: Evaluating the Growth Potential Amidst a Robust 23.5% Revenue Surge

AxoGen, Inc. (NASDAQ: AXGN), a key player in the healthcare sector’s medical devices industry, has been making waves with its innovative solutions for peripheral nerve regeneration and repair. Headquartered in..

Xencor, Inc. (XNCR) Stock Analysis: Exploring a 54% Potential Upside in Biotech Innovation

Xencor, Inc. (NASDAQ: XNCR), an intriguing player in the biotechnology industry, offers a compelling narrative for investors focused on growth and innovation within the healthcare sector. With a market capitalization..

Dianthus Therapeutics, Inc. (DNTH): Investor Outlook on a Promising Biotech with a 41% Potential Upside

Dianthus Therapeutics, Inc. (NASDAQ: DNTH) is catching the eyes of investors with a staggering 41.01% potential upside, according to the latest analyst ratings. This clinical-stage biotechnology company is making strides..

Valneva SE (VALN) Stock Analysis: Navigating the Healthcare Sector with a 30% Potential Upside

Valneva SE (VALN), a French biotech firm specializing in the development and commercialization of vaccines for unmet medical needs, presents a compelling narrative for investors keen on the healthcare sector...

Spyre Therapeutics, Inc. (SYRE): Unlocking 59% Potential Upside in Biotechnology

Spyre Therapeutics, Inc. (SYRE) stands out as a promising player in the biotechnology sector, particularly for investors eyeing significant growth prospects. As a clinical-stage biotech company, Spyre is focused on..

CorMedix Inc. (CRMD) Stock Analysis: A Biotech Gem with a 78.57% Potential Upside

Investors with a keen eye on the biotechnology sector may find CorMedix Inc. (NASDAQ: CRMD) a compelling opportunity. With a significant potential upside of 78.57%, as indicated by its average..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: A Potential 135% Upside Awaits Investors

Niagen Bioscience, Inc. (NAGE), a U.S.-based biotechnology company specializing in healthy aging products, is garnering significant attention with a market capitalization of $534.7 million. Amidst the ever-evolving healthcare sector, Niagen..

Embecta Corp. (EMBC): Investor Outlook with a 42.69% Potential Upside in the Healthcare Sector

Embecta Corp. (NASDAQ: EMBC), a stalwart in the healthcare sector, is drawing attention from investors with its significant potential upside. Specializing in medical instruments and supplies, particularly for diabetes care,..

uniQure N.V. (QURE) Stock Analysis: Uncovering a Potential 158.78% Upside in the Biotech Sector

In the dynamic landscape of biotechnology, uniQure N.V. (NASDAQ: QURE), a Netherlands-based company, is capturing investor attention with a striking potential upside of 158.78%, according to analyst consensus. This biotech..

Butterfly Network, Inc. (BFLY) Stock Analysis: Uncovering a 28% Upside Potential in the Medical Devices Industry

Butterfly Network, Inc. (BFLY), a pioneering company in the medical devices sector, has captured the attention of investors with its innovative approach to ultrasound imaging solutions. As a leading player..

Simulations Plus, Inc. (SLP): Investor Outlook Reveals 9% Potential Upside Amidst Unique Software Offerings

Investors with an eye on innovation in the healthcare technology sector might find Simulations Plus, Inc. (SLP) an intriguing prospect. The company, a staple in the Health Information Services industry,..

InMode Ltd. (INMD) Stock Analysis: Navigating the Healthcare Industry with a 17.15% Potential Upside

Investors eyeing the healthcare sector should consider InMode Ltd. (NASDAQ: INMD), a promising player in the medical devices industry with a notable potential upside of 17.15%. Based in Israel, InMode..

SI-BONE, Inc. (SIBN) Stock Analysis: Unveiling a 31% Potential Upside in the Medical Devices Sector

SI-BONE, Inc. (SIBN) is gaining attention in the healthcare sector, particularly within the medical devices industry, as it showcases a compelling growth narrative. Headquartered in Santa Clara, California, SI-BONE focuses..

Taysha Gene Therapies (TSHA) Stock Analysis: Promising Upside of 108.92% Amidst Biotech Innovation

Taysha Gene Therapies, Inc. (NASDAQ: TSHA) has captured investor attention with a formidable potential upside of 108.92%, according to analyst ratings. This impressive figure is set against the backdrop of..

Kura Oncology (KURA) Stock Analysis: A Biotech with 175% Potential Upside

Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company, is capturing investor attention with its robust pipeline focused on developing innovative cancer treatments. Headquartered in San Diego, California, Kura Oncology..

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: Exploring a 239.62% Potential Upside

Akebia Therapeutics, Inc. (AKBA), a dynamic player in the healthcare sector, has garnered significant attention, particularly in the specialty and generic drug manufacturing industry. With its focus on developing therapeutics..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds